135 related articles for article (PubMed ID: 38346472)
1. Incidence of drug-induced hypersensitivity syndrome associated with levetiracetam and clobazam is likely underreported.
Kichili NR; Hansen A; Kagithala D; Gonzalez AM; Wilkerson M
Ann Allergy Asthma Immunol; 2024 May; 132(5):652-653. PubMed ID: 38346472
[No Abstract] [Full Text] [Related]
2. Double trouble: a case of DRESS syndrome induced by lamotrigine and subsequent skin reaction to levetiracetam.
Wach A; Kosałka-Węgiel J; Korkosz M
Pol Arch Intern Med; 2024 Jun; 134(6):. PubMed ID: 38619333
[No Abstract] [Full Text] [Related]
3. Dress syndrome induced by levetiracetam.
Eleni K
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):377-378. PubMed ID: 24397826
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome.
Rodríguez-Osorio X; Pardo J; López-González FJ; Novoa D; Pintos E
J Clin Neurosci; 2014 May; 21(5):859-60. PubMed ID: 24238830
[TBL] [Abstract][Full Text] [Related]
5. A Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Clobazam.
Manyas H; Paketci C; Okur D; Bayram E; Hiz S; Yis U
Pediatr Emerg Care; 2020 Mar; 36(3):e175. PubMed ID: 30870346
[No Abstract] [Full Text] [Related]
6. Recrudescence of Severe Carbamazepine- Induced DRESS Syndrome after Initiation of Levetiracetam.
Jiang SW; Floyd L; Cardones AR; Selim MA; Shearer SM
Skinmed; 2023; 21(6):445-447. PubMed ID: 38051248
[TBL] [Abstract][Full Text] [Related]
7. Immediate hypersensitivity reaction to levetiracetam: a case report study.
Hosseini MS; Namazi S
Daru; 2024 Jun; 32(1):435-438. PubMed ID: 37914917
[TBL] [Abstract][Full Text] [Related]
8. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel signal of clobazam-associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis.
Sharma A; Kumar A
Acta Neurol Scand; 2022 Nov; 146(5):623-627. PubMed ID: 36029138
[TBL] [Abstract][Full Text] [Related]
10. Comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
Zhang Y; Zhang Q; Zhang J
Pharmacotherapy; 2024 May; 44(5):409-410. PubMed ID: 38853609
[No Abstract] [Full Text] [Related]
11. Cross-sensitivity of Levetiracetam and Carbamazepine Induced Skin Rash.
Panda S
J Assoc Physicians India; 2019 Apr; 67(4):89-90. PubMed ID: 31299852
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam-induced acute psychosis in a child.
Zaki SA; Gupta S
Indian J Pharmacol; 2014; 46(3):341-2. PubMed ID: 24987186
[TBL] [Abstract][Full Text] [Related]
13. Response to comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
Price L; Garrity L; Stiehl S
Pharmacotherapy; 2024 May; 44(5):411-412. PubMed ID: 38853603
[No Abstract] [Full Text] [Related]
14. Levetiracetam associated acute hepatic failure requiring liver transplantation: case report.
Selvaraj V; Madabushi JS; Gunasekar P; Singh SP
J Neurol; 2016 Apr; 263(4):814-5. PubMed ID: 26902232
[No Abstract] [Full Text] [Related]
15. Levetiracetam-associated hyponatremia.
Belcastro V; Costa C; Striano P
Seizure; 2008 Jun; 17(4):389-90. PubMed ID: 18584781
[No Abstract] [Full Text] [Related]
16. Landau-Kleffner syndrome responsive to levetiracetam.
Kossoff EH; Boatman D; Freeman JM
Epilepsy Behav; 2003 Oct; 4(5):571-5. PubMed ID: 14527502
[TBL] [Abstract][Full Text] [Related]
17. [Levetiracetam and restless leg syndrome].
Lasaosa SS; Pellicer PL; Fernández LG
Neurologia; 2008; 23(6):395-6. PubMed ID: 18597196
[No Abstract] [Full Text] [Related]
18. Levetiracetam-induced thrombocytopenia.
Kimland E; Höjeberg B; von Euler M
Epilepsia; 2004 Jul; 45(7):877-8. PubMed ID: 15230717
[No Abstract] [Full Text] [Related]
19. Toxic epidermal necrolysis associated with the use of levetiracetam.
Sierra-Gordillo Y; Peñaranda-Contreras E; Gomez Arbeláez MM; Moreno-Lucero PA
Clin Toxicol (Phila); 2024 Mar; 62(3):201-202. PubMed ID: 38619013
[No Abstract] [Full Text] [Related]
20. Long-term continuation of levetiracetam in patients with refractory epilepsy.
Krakow K; Walker M; Otoul C; Sander JW
Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
